InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Mack Anthony P., Chairman & CEO. Officer active across 1 companies, notably Virpax Pharmaceuticals, Inc.. Cumulatively, 3 disclosures have been logged. Total volume traded: €274k. The latest transaction was filed on 18 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
€96,92375,750 shares@ €1.27953.15% mcap35.4% of flow
Common Stock, $0.00001 par value
SEC:0001493152-22-014659:0·
Ideal exit: 12 Feb 2023 (T+270)
€88,55025,125 shares@ €3.5244100.0% of flow
Common Stock, $0.00001 par value
SEC:0000905718-21-001521·
Ideal exit: 15 Aug 2022 (T+270)
€88,55025,125 shares@ €3.52442.88% mcap32.3% of flow
Common Stock, $0.00001 par value
SEC:0000905718-21-001521:0·
Ideal exit: 15 Aug 2022 (T+270)
3 of 3 declarations
About Mack Anthony P.
Mack Anthony P. is the President and CEO of Virpax Pharmaceuticals, Inc. He oversees the company's operations and leads strategic initiatives to develop innovative treatments in the pharmaceutical sector.
